Ulrich Karl Walter Spengler
Amministratore Delegato presso altona Diagnostics GmbH
Posizioni attive di Ulrich Karl Walter Spengler
Società | Posizione | Inizio | Fine |
---|---|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Direttore/Membro del Consiglio | 01/01/2013 | - |
LISCO Beteiligungs - Und Beratungsgesellschaft mbH | Direttore/Membro del Consiglio | - | - |
altona Diagnostics GmbH
altona Diagnostics GmbH Medical SpecialtiesHealth Technology Altona Diagnostics GmbH develops and commercializes polymerase chain reaction based assays and molecular diagnostic test solutions in the field of infectious diseases. The private company is based in Hamburg, DE. and has subsidiaries in United Kingdom. The German company was founded in 1998 by Ulrich Karl Walter Spengler. Ulrich Karl Walter Spengler has been the CEO since 1998. | Amministratore Delegato | 01/01/1998 | - |
Fondatore | 01/01/1998 | - | |
Altona Diagnostics UK Ltd.
Altona Diagnostics UK Ltd. Medical SpecialtiesHealth Technology Part of Altona Diagnostics GmbH, Altona Diagnostics UK Ltd. is a medical diagnostics company based in Liverpool, UK. The British company's product lines include Altostar®, Flexstar®, and Realstar®, which cater to individual lab requirements. Altona Diagnostics also provides SARS-CoV-2 real-time PCR test kits, including current reactivity analyses in response to mutations, and two RealStar® PCR malaria kits to help combat malaria. Founded in 2017, the company develops and manufactures in vitro diagnostic tests for the PCR-based detection of pathogens such as viruses, bacteria, or parasites. | Direttore/Membro del Consiglio | 27/02/2017 | - |
Storia della carriera di Ulrich Karl Walter Spengler
Precedenti posizioni note di Ulrich Karl Walter Spengler
Società | Posizione | Inizio | Fine |
---|---|---|---|
2CUREX AB | Direttore/Membro del Consiglio | 01/01/2017 | 02/04/2019 |
Artus GmbH Personaldienst | Fondatore | - | - |
Statistiche
Distribuzione geografica
Germania | 4 |
Danimarca | 2 |
Svezia | 2 |
Posizioni
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Founder | 2 |
Settori
Health Technology | 5 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
2CUREX AB | Health Technology |
Aziende private | 5 |
---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
Artus GmbH Personaldienst | Commercial Services |
altona Diagnostics GmbH
altona Diagnostics GmbH Medical SpecialtiesHealth Technology Altona Diagnostics GmbH develops and commercializes polymerase chain reaction based assays and molecular diagnostic test solutions in the field of infectious diseases. The private company is based in Hamburg, DE. and has subsidiaries in United Kingdom. The German company was founded in 1998 by Ulrich Karl Walter Spengler. Ulrich Karl Walter Spengler has been the CEO since 1998. | Health Technology |
LISCO Beteiligungs - Und Beratungsgesellschaft mbH | |
Altona Diagnostics UK Ltd.
Altona Diagnostics UK Ltd. Medical SpecialtiesHealth Technology Part of Altona Diagnostics GmbH, Altona Diagnostics UK Ltd. is a medical diagnostics company based in Liverpool, UK. The British company's product lines include Altostar®, Flexstar®, and Realstar®, which cater to individual lab requirements. Altona Diagnostics also provides SARS-CoV-2 real-time PCR test kits, including current reactivity analyses in response to mutations, and two RealStar® PCR malaria kits to help combat malaria. Founded in 2017, the company develops and manufactures in vitro diagnostic tests for the PCR-based detection of pathogens such as viruses, bacteria, or parasites. | Health Technology |